Author/Authors :
Paul Calès، نويسنده , , Pascal Veillon، نويسنده , , Anselme Konaté، نويسنده , , Elisabeth Mathieu، نويسنده , , Catherine Ternisien، نويسنده , , Alain Chevailler، نويسنده , , Alban Godon، نويسنده , , Yves Gallois، نويسنده , , Françoise Joubaud، نويسنده , , Isabelle Hubert-Fouchard، نويسنده , , Frédéric Oberti، نويسنده , , Stéphane Réaud، نويسنده , , Gilles Hunault، نويسنده , , Françoise Mauriat، نويسنده , , Françoise Lunel-Fabiani، نويسنده ,
Abstract :
Objectives:
To evaluate the inter-laboratory reproducibility of blood test for liver fibrosis: FibroMeter, Fibrotest, APRI and their composites variables.
Design and methods:
Four studies, including 147 patients, were performed: study #1 included 2 metachronous blood samples and 2 laboratories; studies #2, #3 and #4 included synchronous samples with assays delayed at day 1 in 12 laboratories, at day 0 in 10 laboratories and at day 0 or 1 in 2 laboratories, respectively. Agreement was evaluated by the intraclass correlation coefficient (ric).
Results:
In studies #1, #2 and #4, ric for FibroMeter was 0.893, 0.942 and 0.991, respectively. In study #3, the ric were: FibroMeter: 0.963, Fibrotest: 0.984, APRI: 0.949. Large simulated variations in composite variables had a weak impact on FibroMeter.
Conclusions:
When blood marker limits are controlled, inter-laboratory agreement of blood tests is excellent in clinical practice conditions. Blood tests are robust against the variability of composite blood variables.
Keywords :
serum markers , Liver fibrosis , Analytical variability , Inter-laboratory reproducibility